Category | Treatment Decision, n (%) | Change Because of Side Effects | HAQ-II, mean (SD) | Pain, mean (SD) | Patient Global, mean (SD) | ||
---|---|---|---|---|---|---|---|
No Change | Increased Intensity | Decreased Intensity | |||||
Rheumatoid arthritis | 118 (40.0) | 140 (47.5) | 28 (9.5) | 9 (3.1) | 0.95 (0.65) | 4.11 (2.78) | 3.78 (2.58) |
Other inflammatory arthritis | 116 (42.6) | 131 (48.2) | 15 (5.5) | 10 (3.7) | 0.77 (0.62) | 4.06 (2.78) | 3.86 (2.63) |
Noninflammatory disorder | 37 (49.3) | 36 (48.0) | 2 (2.7) | 0 (0.0) | 1.06 (0.65) | 5.18 (2.58) | 4.75 (2.51) |
Autoimmune connective tissue disease | 55 (50.5) | 40 (36.7) | 10 (9.2) | 4 (3.7) | 0.70 (0.59) | 3.56 (2.80) | 3.73 (2.65) |
Other | 60 (45.5) | 40 (30.3) | 30 (22.7) | 2 (1.5) | 0.84 (0.69) | 3.93 (3.03) | 3.54 (2.63) |
PAS: Patient Activity Scale; HAQ: Health Assessment Questionnaire.